Page last updated: 2024-12-05

phenethyl isothiocyanate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Phenethyl isothiocyanate (PEITC) is a naturally occurring isothiocyanate found in cruciferous vegetables such as broccoli, Brussels sprouts, and cauliflower. It is formed from the enzymatic breakdown of the glucosinolate glucobrassicin by the enzyme myrosinase. PEITC has been shown to possess various biological activities, including anticancer, antioxidant, anti-inflammatory, and antimicrobial effects. Its anti-cancer properties have been attributed to its ability to induce apoptosis, inhibit cell proliferation, and induce cell cycle arrest in cancer cells. PEITC has also been shown to protect against oxidative stress and inflammation by scavenging free radicals and inhibiting the production of pro-inflammatory cytokines. In addition, PEITC has been reported to have antimicrobial activity against various bacteria and fungi. The potential health benefits of PEITC have led to extensive research on its biological activities and mechanisms of action. It is being investigated as a potential therapeutic agent for the prevention and treatment of various diseases, including cancer, cardiovascular disease, and neurodegenerative disorders.'

phenethyl isothiocyanate: a dietary liver aldehyde dehydrogenase inhibitor; promotes urinary bladder carcinoma [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

phenethyl isothiocyanate : An isothiocyanate having a phenethyl group attached to the nitrogen. It is a naturally occurring compound found in some cruciferous vegetables (e.g. watercress) and is known to possess anticancer properties. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID16741
CHEMBL ID151649
CHEBI ID351346
SCHEMBL ID156960
MeSH IDM0162652

Synonyms (84)

Synonym
HMS1783C17
AC-12769
NCI60_041942
(2-isothiocyanatoethyl)benzene
ccris 3146
phenylaethylsenfoel [german]
peitc
nsc 87868
einecs 218-855-5
brn 2084162
phenethylisothiocyanate
beta-phenylethyl isothiocyanate
nsc87868
wln: scn2r
2-phenylethyl isothiocyanate
.beta.-phenylethyl isothiocyanate
benzene, (2-isothiocyanatoethyl)-
isothiocyanic acid, phenethyl ester
phenethyl isothiocyanate
phenylaethylsenfoel
.beta.-phenethyl isothiocyanate
nsc-87868
2257-09-2
phenylethyl isothiocyanate
2-phenylethyl isothiocyanate, fg
phenethyl isothiocyanate, 99%
STK397325
bdbm50240850
(2-isothiocyanato-ethyl)-benzene
CHEMBL151649 ,
2-isothiocyanatoethylbenzene
izjdokydewtzso-uhfffaoysa-
inchi=1/c9h9ns/c11-8-10-7-6-9-4-2-1-3-5-9/h1-5h,6-7h2
P0986
isothiocyanic acid 2-phenylethyl ester
beta-phenethyl isothiocyanate
chebi:351346 ,
AKOS000119469
NCGC00248526-01
6u7tfk75kv ,
unii-6u7tfk75kv
4-12-00-02476 (beilstein handbook reference)
dtxcid901120
dtxsid5021120 ,
cas-2257-09-2
NCGC00257654-01
tox21_200100
ss-phenethyl isothiocyanate
A816267
BBL009999
BRD-K56700933-001-02-1
BP-12941
FT-0604634
EPITOPE ID:138724
fema no. 4014
phenethyl isothiocyanate [mi]
phenylethyl isothiocyanate [fhfi]
SCHEMBL156960
phenethyl-isothiocyanate
2-phenylethylisothiocyanate
1-(2-isothiocyanatoethyl)benzene
W-107466
(2-isothiocyanatoethyl)benzene #
isothiocyanic acid .beta.-phenylethyl ester
mfcd00004821
1-isothiocyanato-2-phenylethane
J-802164
phenethyl isothiocyanate, analytical standard
(2-isothiocyanatoethyl)benzene, 9ci
DB12695
F0001-0795
jc-5411
AS-17373
Q7181339
EN300-17386
HMS3870G13
1-isothiocyanato-2-phenylethane (1,1,2,2-d4)
D92051
jc 5411jc-5411
jc 5411
jc5411
HY-23155
2-phenyl ethyl isothiocyanate
Z56924472

Research Excerpts

Overview

Phenethyl isothiocyanate (PEITC) is a natural product found as a conjugate in cruciferous vegetables. It is an important degradation product of glucosinolates (GSLs), belonging to an anti-nutritional factor.

ExcerptReferenceRelevance
"Phenethyl isothiocyanate (1) is a natural dietary phytochemical with cytostatic, cytotoxic, and antitumor activity. "( Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2.
Cavell, BE; Donlevy, AM; Packham, G; Proud, CG; Syed Alwi, SS, 2012
)
2.08
"2-Phenethyl isothiocyanate (PEITC) is a natural product found as a conjugate in cruciferous vegetables. "( Effects of 2-Phenethyl Isothiocyanate on Metabolism of 1,3-Butadiene in Smokers.
Boldry, EJ; Carmella, SG; Hatsukami, DK; Hecht, SS; Tessier, K; Tretyakova, NY; Wang, R; Yuan, JM, 2020
)
1.65
"Phenethyl isothiocyanate (PEITC) is a novel epigenetic regulator derived from cruciferous vegetables that has marked antitumor effects."( Phenethyl isothiocyanate reduces breast cancer stem cell-like properties by epigenetic reactivation of CDH1.
Hao, M; Zhang, T; Zhang, W, 2021
)
2.79
"Phenethyl isothiocyanate (PEITC) is an important degradation product of glucosinolates (GSLs), belonging to an anti-nutritional factor that affects the digestion and absorption of nutrients in the animals' intestinal."( Nontoxic dose of Phenethyl isothiocyanate ameliorates deoxynivalenol-induced cytotoxicity and inflammation in IPEC-J2 cells.
Gan, F; Ge, L; Hou, L; Huang, K; Le, G; Lin, Z; Liu, S; Mao, X; Wen, L, 2021
)
1.68
"Phenethyl isothiocyanate (PEITC) is a glucosinolate derived from cruciferous vegetables and is a cancer-chemopreventive reagent. "( Cancer-preventive effect of phenethyl isothiocyanate through tumor microenvironment regulation in a colorectal cancer stem cell xenograft model.
Cho, YS; Lim, E; Nho, CW; Shin, JM, 2021
)
2.36
"Phenethyl isothiocyanate (PEITC) is a naturally occurring isothiocyanate well known for its antioxidant and anti-inflammatory effects, yet its reno-preventive effects against DN has not been investigated."( Phenethyl isothiocyanate attenuates diabetic nephropathy via modulation of glycative/oxidative/inflammatory signaling in diabetic rats.
Eisa, NH; El-Sherbiny, M; Elsherbiny, NM; Khodir, AE; Said, E, 2021
)
2.79
"Phenethyl isothiocyanate (PEITC) is a natural compound found in cruciferous vegetables such as broccoli and is used as a cancer chemopreventive agent; however, its effects on CSCs are little known."( Phenethyl isothiocyanate suppresses cancer stem cell properties in vitro and in a xenograft model.
Jung, SH; Kim, J; Kim, JH; Kim, KA; Kim, SY; Nho, CW; Shin, JM; Yoo, G; Yun, JH, 2017
)
2.62
"Phenethyl isothiocyanate (PEITC) is a natural compound abundant in cruciferous vegetables. "( Inhibition of autophagy potentiates the anti-metastasis effect of phenethyl isothiocyanate through JAK2/STAT3 pathway in lung cancer cells.
Cao, L; Meng, Z; Song, Q; Wang, H; Wang, L; Wu, X; Xu, K; Zhang, Q, 2018
)
2.16
"Phenethyl isothiocyanate (PEITC) is a naturally occurring compound found in some cruciferous vegetables. "( Phenethyl isothiocyanate in combination with dibenzoylmethane inhibits the androgen-independent growth of prostate cancer cells.
Goodin, S; He, Y; Huang, H; Li, D; Liu, W; Xiang, H; Xu, XT; Zhang, K; Zhang, L; Zheng, X, 2018
)
3.37
"Phenethyl isothiocyanate (PEITC) is a potential cancer prevention agent that is found in cruciferous vegetables. "( Suppression of glutathione S-transferases potentiates the cytotoxic effect of phenethyl isothiocyanate in cholangiocarcinoma cells.
Khunluck, T; Kukongviriyapan, U; Kukongviriyapan, V; Prawan, A; Senggunprai, L; Tusskorn, O, 2018
)
2.15
"Phenethyl isothiocyanate (PEITC) is a natural product obtained from cruciferous vegetables with anticancer activities."( Phenethyl isothiocyanate inhibits colorectal cancer stem cells by suppressing Wnt/β-catenin pathway.
Cao, WS; Chen, JQ; Chen, Y; Geng, SS; Han, HY; Li, XT; Li, Y; Meng, Y; Wang, XQ; Wu, JS; Xie, CF; Zhang, Q; Zhong, CY; Zhu, JY, 2018
)
2.64
"Phenethyl isothiocyanate (PEITC) is an aromatic isothiocyanate present in cruciferous vegetables. "( Phenethyl isothiocyanate stimulates glucose uptake through the Akt pathway in C2C12 myotubes.
Chiba, M; Ito, Y; Nagasawa, T, 2019
)
3.4
"Phenethyl isothiocyanate (PEITC) is a natural compound that is involved in chemoprevention as well as inhibition of cell growth and induction of apoptosis in several types of cancer cells. "( Phenethyl isothiocyanate suppresses EGF-stimulated SAS human oral squamous carcinoma cell invasion by targeting EGF receptor signaling.
Amagaya, S; Chen, HJ; Lee, CY; Lin, CM; Lin, YC; Shih, NC; Yang, JS, 2013
)
3.28
"Phenethyl isothiocyanate (PEITC) is a natural isothiocyanate with anticancer activity against many drug-resistant cancer cells. "( Phenethyl isothiocyanate induces apoptosis of cholangiocarcinoma cells through interruption of glutathione and mitochondrial pathway.
Kukongviriyapan, U; Kukongviriyapan, V; Prawan, A; Senggunprai, L; Tusskorn, O, 2013
)
3.28
"Phenethyl isothiocyanate (PEITC) is a cancer chemopreventive agent from cruciferous vegetables. "( Phenethyl isothiocyanate induces calcium mobilization and mitochondrial cell death pathway in cholangiocarcinoma KKU-M214 cells.
Kukongviriyapan, U; Kukongviriyapan, V; Prawan, A; Senggunprai, L; Tusskorn, O, 2013
)
3.28
"Phenethyl isothiocyanate (PEITC) is an isothiocyanate found in watercress as the glucosinolate (gluconasturtiin). "( Induction of epoxide hydrolase, glucuronosyl transferase, and sulfotransferase by phenethyl isothiocyanate in male Wistar albino rats.
Abdull Razis, AF; Konsue, N; Mohd Noor, N, 2014
)
2.07
"Phenethyl isothiocyanate (PEITC) is a naturally occurring cruciferous vegetable-derived compound that inhibits cell growth and induces apoptosis in oral cancer cells. "( Phenethyl isothiocyanate induces DNA damage-associated G2/M arrest and subsequent apoptosis in oral cancer cells with varying p53 mutations.
Chen, ZF; Huang, SY; Lee, KJ; Lin, JS; Shyu, HW; Su, SH; Su, SJ; Yeh, H; Yeh, YT, 2014
)
3.29
"Phenethyl isothiocyanate (PEITC) is a promising chemopreventive agent present in cruciferous vegetables. "( Development and validation of an LC-APCI-MS/MS method for the determination of phenethyl isothiocyanate in human plasma.
Zheng, F; Zheng, L, 2015
)
2.09
"Phenethyl isothiocyanate (PEITC) is an active component extracted from cruciferous plants that has exhibited anticancer activity in various types of human cancer; however, its effect on the inhibition of metastasis remains unclear."( Phenethyl isothiocyanate suppresses cervical carcinoma metastasis potential and its molecular mechanism.
Bao, L; Chen, Y; Fu, X; Hao, Q; Liu, W; Wu, H; Zhang, L, 2014
)
2.57
"β-Phenethyl isothiocyanate (PEITC) is an important phytochemical from cruciferous vegetables and is being evaluated for chemotherapeutic activity in early phase clinical trials. "( Advances in molecular signaling mechanisms of β-phenethyl isothiocyanate antitumor effects.
Hu, L; Lv, QL; Qin, CZ; Shen, DY; Wen, CJ; Wu, LX; Zhang, X; Zhou, HH, 2015
)
1.39
"Phenethyl isothiocyanate (PEITC) is a more potent inducer of apoptosis than sulforaphane (SFN) in A549 cells, but SFN induces more ROS generation and oxidative damages than PEITC, suggesting that oxidative stress again is probably not a trigger for apoptosis in these cells."( Binding to protein by isothiocyanates: a potential mechanism for apoptosis induction in human non small lung cancer cells.
Chung, FL; Mi, L, 2008
)
1.07
"Phenethyl isothiocyanate (PEITC) is a promising cancer chemopreventive agent but the mechanism of its anticancer effect is not fully understood. "( Atg5 regulates phenethyl isothiocyanate-induced autophagic and apoptotic cell death in human prostate cancer cells.
Bommareddy, A; Fisher, AL; Hahm, ER; Jiang, Y; Powolny, AA; Singh, SV; Xiao, D, 2009
)
2.15
"Phenethyl isothiocyanate is a chemopreventive phytochemical present in cruciferous vegetables where it exists as the glucosinolate gluconasturtiin. "( Phenethyl isocyanate is not the metabolite of phenethyl isothiocyanate responsible for mechanism-based inhibition of cytochrome P450.
Ioannides, C; Konsue, N, 2010
)
2.06
"Phenethyl isothiocyanate (PEITC) is a constituent of edible cruciferous vegetables and has received attention due to its potential cancer chemopreventive activity. "( Phthalate esters reveal skin-sensitizing activity of phenethyl isothiocyanate in mice.
Iizuka, H; Imai, Y; Kondo, A; Kurohane, K; Maruyama, T; Matsuda, T; Tamai, T, 2010
)
2.05
"Phenethyl isothiocyanate (PEITC) is a constituent of cruciferous vegetables that has demonstrated cancer preventive activity in a number of cancer models including lung, prostate, and breast cancer. "( Effect of orally administered phenethyl isothiocyanate on hepatic gene expression in rats.
Morris, ME; Telang, U, 2010
)
2.09
"Phenethyl isothiocyanate (PEITC) is a highly promising cancer chemopreventive constituent of cruciferous vegetables (e.g., watercress) with in vivo efficacy in experimental rodent cancer models. "( Bim contributes to phenethyl isothiocyanate-induced apoptosis in breast cancer cells.
Hahm, ER; Singh, SV, 2012
)
2.15
"β-Phenethyl isothiocyanate (PEITC) is a natural product with potent anticancer activity against human leukemia cells including drug-resistant primary leukemia cells from patients. "( Inhibition of mitochondrial respiration and rapid depletion of mitochondrial glutathione by β-phenethyl isothiocyanate: mechanisms for anti-leukemia activity.
Chen, G; Chen, Z; Hu, Y; Huang, P, 2011
)
1.31
"Phenethyl isothiocyanate (PEITC) is a promising cancer chemopreventive component of edible cruciferous vegetables with in vivo efficacy against prostate cancer in experimental rodents. "( Notch activation by phenethyl isothiocyanate attenuates its inhibitory effect on prostate cancer cell migration.
Hahm, ER; Kim, SH; Sakao, K; Sehrawat, A; Singh, SV, 2011
)
2.14
"Phenethyl isothiocyanate (PEITC) is a candidate anticancer compound found in certain cruciferous vegetables. "( Inhibition of androgen-responsive LNCaP prostate cancer cell tumor xenograft growth by dietary phenethyl isothiocyanate correlates with decreased angiogenesis and inhibition of cell attachment.
Hudson, TS; Hursting, SD; Kim, YS; Perkins, SN; Wang, TC; Wang, TT; Young, HA, 2012
)
2.03
"Phenethyl isothiocyanate (PEITC) is a naturally occurring electrophile which depletes intracellular glutathione (GSH) levels and triggers accumulation of reactive oxygen species (ROS). "( Differential induction of apoptosis in human breast cancer cell lines by phenethyl isothiocyanate, a glutathione depleting agent.
Cavell, BE; Donlevy, A; Packham, G; Syed Alwi, SS, 2012
)
2.05
"Phenethyl isothiocyanate (PEITC) is a natural plant compound with chemopreventative potential against some cancers and the ability to induce apoptosis in breast cancer cells."( Biomarkers of phenethyl isothiocyanate-mediated mammary cancer chemoprevention in a clinically relevant mouse model.
Arlotti, JA; Beumer, JH; Chandra-Kuntal, K; Dhir, R; Hahm, ER; Jankowitz, RC; Kim, SH; Lee, J; Powolny, AA; Sakao, K; Sehrawat, A; Singh, SV, 2012
)
2.18
"Phenethyl isothiocyanate (PEITC) is a promising cancer chemopreventive agent commonly found in edible cruciferous vegetables. "( Tumor regression by phenethyl isothiocyanate involves DDB2.
Bagchi, S; Elangovan, I; Kopanja, D; Raychaudhuri, P; Roy, N, 2013
)
2.16
"Phenethyl isothiocyanate (PEITC) is a potential chemopreventive agent that is present naturally in widely consumed vegetables, especially in watercress. "( The roles of JNK and apoptotic signaling pathways in PEITC-mediated responses in human HT-29 colon adenocarcinoma cells.
Chen, C; Hebbar, V; Hu, R; Kim, BR; Kong, AN, 2003
)
1.76
"Phenethyl isothiocyanate (PEITC) is a dietary compound present in cruciferous vegetables that has cancer-preventive properties. "( Determination of phenethyl isothiocyanate in human plasma and urine by ammonia derivatization and liquid chromatography-tandem mass spectrometry.
Ji, Y; Morris, ME, 2003
)
2.1
"Phenethyl isothiocyanate (PEITC) is a dietary component present in cruciferous vegetables and reported to have chemopreventive properties. "( Pharmacokinetics of dietary phenethyl isothiocyanate in rats.
Ji, Y; Kuo, Y; Morris, ME, 2005
)
2.07
"Phenethyl isothiocyanate (PEITC) is a promising chemopreventive agent that exerts its effects by induction of phase II enzymes via activation of Nrf2."( Identification of Nrf2-regulated genes induced by chemopreventive isothiocyanate PEITC by oligonucleotide microarray.
Chan, JY; Gopalkrishnan, A; Hu, R; Jain, MR; Khor, TO; Kong, AN; Lin, W; Reddy, B; Shen, G; Xu, C, 2006
)
1.06
"Phenethyl isothiocyanate (PEITC) is an isothiocyanate which is a major constituent of watercress and other cruciferous vegetables. "( Chemoprevention of familial adenomatous polyposis in Apc(Min/+) mice by phenethyl isothiocyanate (PEITC).
Cheung, WK; Khor, TO; Kong, AN; Prawan, A; Reddy, BS, 2008
)
2.02
"Phenethyl isothiocyanate (PEITC) is a natural product that is among the most effective cancer chemopreventive agents known. "( Essential role of p53 in phenethyl isothiocyanate-induced apoptosis.
Dong, Z; Hecht, SS; Huang, C; Li, J; Ma, WY, 1998
)
2.05
"Phenethyl isothiocyanate (PEITC) is an effective inhibitor of lung tumorigenesis induced in rats and mice by the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) while benzyl isothiocyanate (BITC) inhibits lung tumorigenesis induced in mice by another tobacco smoke carcinogen, benzo[a]pyrene (BaP). "( Effects of phenethyl isothiocyanate and benzyl isothiocyanate, individually and in combination, on lung tumorigenesis induced in A/J mice by benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Hecht, SS; Kenney, PM; Trushin, N; Upadhyaya, P; Wang, M, 2000
)
2.14

Effects

Phenethyl isothiocyanate (PEITC) has been implicated in inhibiting metastasis of several types of human cancer. It has certain interference effects on the expression of developmental genes (pax-6, netrin-1)

ExcerptReferenceRelevance
"Phenethyl isothiocyanate (PEITC) has been implicated in inhibiting metastasis of several types of human cancer."( PEITC reverse multi-drug resistance of human gastric cancer SGC7901/DDP cell line.
Liu, YF; Song, X; Tang, T; Wang, WY, 2014
)
1.12
"Phenethyl isothiocyanate has certain interference effects on the expression of developmental genes (pax-6, netrin-1) during the process of the ESCs' differentiation through suppressing PKC alpha expression."( [Effect of phenethyl isothiocyanate on expression of genes during differentiation process of mouse embryonic stem cells in vitro].
Xu, H; Yu, Z, 2008
)
2.18
"Phenethyl isothiocyanate (PEITC) has been of great interest as a promising cancer chemopreventive agent. "( Involvement of Nrf2 and JNK1 in the activation of antioxidant responsive element (ARE) by chemopreventive agent phenethyl isothiocyanate (PEITC).
Hu, R; Keum, YS; Kim, BR; Kong, AN; Owuor, ED, 2003
)
1.97

Toxicity

ExcerptReferenceRelevance
" It is proposed that the presence of such selectively toxic compounds in the diet may inhibit the development of tumors by interfering with the growth of preneoplastic lesions while having little effect on normal cells."( Selective toxicity of compounds naturally present in food toward the transformed phenotype of human colorectal cell line HT29.
Fyfe, D; Johnson, IT; Musk, SR; Smith, TK; Stening, P; Stephenson, P, 1995
)
0.29
" When PEITC (19-150 micromol/kg) was given to mice intragastrically 1 hr before or immediately prior to a toxic dose of APAP, the APAP-induced hepatotoxicity was significantly decreased or was completely prevented."( Effects of phenethyl isothiocyanate on acetaminophen metabolism and hepatotoxicity in mice.
Chen, L; Li, Y; Reuhl, KR; Stein, AP; Wang, EJ; Yang, CS, 1997
)
0.69
" Dose-response curves revealed that PEITC was significantly more toxic in tumorigenic and non-tumorigenic cells relative to PHITC."( Comparison of phenethyl and 6-phenylhexyl isothiocyanate-induced toxicity in rat esophageal cell lines with and without glutathione depletion.
Hudson, TS; Mallery, SR; Morse, MA; Stoner, GD; Young, H, 2005
)
0.33
"The intestinal tract is a target for the deoxynivalenol (DON), which has adverse effects in animals and humans' health by affecting intestinal functions."( Nontoxic dose of Phenethyl isothiocyanate ameliorates deoxynivalenol-induced cytotoxicity and inflammation in IPEC-J2 cells.
Gan, F; Ge, L; Hou, L; Huang, K; Le, G; Lin, Z; Liu, S; Mao, X; Wen, L, 2021
)
0.96
" We determined that liposomal-PEITC-CDDP is much more toxic toward human NSCLC cell lines than it is toward human normal lung cell lines."( A Method for Liposome Co-encapsulation of Phenethyl Isothiocyanate and Cisplatin and Determining Its Toxicity Against Lung and Lung Cancer Cells.
Di Pasqua, AJ; Sun, M, 2021
)
0.89

Pharmacokinetics

ExcerptReferenceRelevance
"9 h, with an elimination half-life (T1/2e) of 21."( Disposition and pharmacokinetics of phenethyl isothiocyanate and 6-phenylhexyl isothiocyanate in F344 rats.
Chung, FL; Conaway, CC; Jiao, D; Kohri, T; Liebes, L, 1999
)
0.58
" Pharmacokinetic analysis was conducted by WinNonlin and ADAPT II."( Pharmacokinetics of dietary phenethyl isothiocyanate in rats.
Ji, Y; Kuo, Y; Morris, ME, 2005
)
0.62
"The principal objective of this study was to evaluate whether repeated oral administration influences the pharmacokinetic behavior of the chemopreventive agent phenethyl isothiocyanate (PEITC) in rat."( Repeated oral administration modulates the pharmacokinetic behavior of the chemopreventive agent phenethyl isothiocyanate in rats.
Ioannides, C; King, LJ; Kirkpatrick, J; Konsue, N; Kuhnert, N, 2010
)
0.77
" Pharmacokinetic features of unchanged PEITC are (I) linear and first-order absorption, (II) high protein binding and capacity-limited tissue distribution, and (III) reversible metabolism and capacity-limited hepatic elimination."( Pharmacokinetics and pharmacodynamics of phenethyl isothiocyanate: implications in breast cancer prevention.
Dave, RA; Morris, ME, 2014
)
0.67

Compound-Compound Interactions

ExcerptReferenceRelevance
"The aim of this study was to investigate the protective effect of isothiocyanates alone or in combination with vitamin C towards N-nitrosodibutylamine (NDBA) or N-nitrosopiperidine (NPIP)-induced oxidative DNA damage in the single cell gel electrophoresis (SCGE)/HepG2 assay."( Protective effects of isothiocyanates alone or in combination with vitamin C towards N-nitrosodibutylamine or N-nitrosopiperidine-induced oxidative DNA damage in the single-cell gel electrophoresis (SCGE)/HepG2 assay.
Arranz, N; García, A; Haza, AI; Morales, P; Rafter, J, 2008
)
0.35
"The hepatic organic anion transporting polypeptides (OATPs) influence the pharmacokinetics of several drug classes and are involved in many clinical drug-drug interactions."( Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR, 2012
)
0.38
" We thus aim at evaluating PEITC used alone or in combination with cisplatin in order to improve MPM treatment."( Cisplatin in combination with Phenethyl Isothiocyanate (PEITC), a potential new therapeutic strategy for malignant pleural mesothelioma.
Blanquart, C; Cellerin, L; Denis, I; Gregoire, M, 2014
)
0.69

Bioavailability

ExcerptReferenceRelevance
" Our objective was to examine the dose-dependent pharmacokinetics and oral bioavailability of unchanged PEITC, as well as its pH- and temperature-dependent stability and its serum protein binding."( Pharmacokinetics of dietary phenethyl isothiocyanate in rats.
Ji, Y; Kuo, Y; Morris, ME, 2005
)
0.62
" Oral bioavailability of PEITC was 115 and 93% at doses of 10 and 100 micromol/kg, respectively."( Pharmacokinetics of dietary phenethyl isothiocyanate in rats.
Ji, Y; Kuo, Y; Morris, ME, 2005
)
0.62
" Following single oral dose administration, PEITC was rapidly absorbed, peak plasma concentrations being attained within the hour, and achieved an absolute bioavailability of 77%, but displayed dose-dependent pharmacokinetics, with bioavailability decreasing and clearance increasing moderately with dose; C(max) values did not rise proportionately to the dose and volume of distribution increased."( Repeated oral administration modulates the pharmacokinetic behavior of the chemopreventive agent phenethyl isothiocyanate in rats.
Ioannides, C; King, LJ; Kirkpatrick, J; Konsue, N; Kuhnert, N, 2010
)
0.58
" Poor bioavailability is the main factor limiting the efficacy of chemopreventive agents."( Nanoparticles increase the efficacy of cancer chemopreventive agents in cells exposed to cigarette smoke condensate.
Fenoglio, D; Filaci, G; Izzotti, A; Lee, JL; Parodi, A; Pulliero, A; Romani, M; Sinkam, PN; Soares, CP; Wu, Y, 2015
)
0.42
" Furthermore, it is hydrophobic and has low stability, bioavailability and bioaccessibility."( Chitosan-olive oil microparticles for phenylethyl isothiocyanate delivery: Optimal formulation.
Coscueta, ER; Pintado, M; Reis, CA; Sousa, AS, 2021
)
0.62
" However, limited water solubility, short half-life, and instability are reasons for the low bioavailability of PEITC that hampers clinical application."( Thermosensitive smart hydrogel of PEITC ameliorates the therapeutic efficacy in rheumatoid arthritis.
Chawla, S; Haloi, P; Konkimalla, VB, 2023
)
0.91

Dosage Studied

ExcerptRelevanceReference
" For both isothiocyanates, there were no statistically significant differences between dosing frequencies in inhibitory effects on tumor multiplicities and tumor incidences."( Effect of frequency of isothiocyanate administration on inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary adenoma formation in A/J mice.
Amin, SG; Chung, FL; Eklind, KI; Morse, MA, 1992
)
0.28
" Using an identical dosing regimen, parallel results were observed in the effects of these isothiocyanates on O6-methylguanine formation in the lung, in which PEITC at either dose resulted in considerable inhibition at 2 or 6 h after NNK administration, while BITC or PITC had little effect."( Effects of aromatic isothiocyanates on tumorigenicity, O6-methylguanine formation, and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung.
Amin, SG; Chung, FL; Hecht, SS; Morse, MA, 1989
)
0.28
" These mice, together with female A/J mice, were treated at 6-8 weeks of age with NNK or dosed with PEITC prior to administration of NNK."( K-ras mutations in lung tumors from A/J and A/J x TSG-p53 F1 mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate.
Anderson, MW; Crist, KA; Kelloff, GJ; Lubet, RA; Matzinger, SA; Pereira, MA; Steele, VE; Stoner, GD; You, M, 1995
)
0.5
" beginning 2 weeks prior to NMBA treatment) or following completion of NMBA dosing only."( Effects of dietary phenethyl isothiocyanate, ellagic acid, sulindac and calcium on the induction and progression of N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats.
Barch, DH; Siglin, JC; Stoner, GD, 1995
)
0.62
" SFN and PEITC and their NAC conjugates were administered by gavage either three times weekly for 8 weeks (5 and 20 micromol, respectively) after AOM dosing (post-initiation stage) or once daily for 3 days (20 and 50 micromol, respectively) before AOM treatment (initiation stage)."( Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate.
Chung, FL; Conaway, CC; Rao, CV; Reddy, BS, 2000
)
0.53
" Dose-response curves revealed that PEITC was significantly more toxic in tumorigenic and non-tumorigenic cells relative to PHITC."( Comparison of phenethyl and 6-phenylhexyl isothiocyanate-induced toxicity in rat esophageal cell lines with and without glutathione depletion.
Hudson, TS; Mallery, SR; Morse, MA; Stoner, GD; Young, H, 2005
)
0.33
" A 50-fold increase in Bcl-2 expression shifted the dose-response curve, with an increase in the phenethyl isothiocyanate LD(50) from 7 to 15 micromol/L, but there was still a complete loss in cell viability at doses in excess of 20 micromol/L."( Phenethyl isothiocyanate triggers apoptosis in Jurkat cells made resistant by the overexpression of Bcl-2.
Brown, KK; Hampton, MB; Pullar, JM; Thomson, SJ, 2006
)
1.99
"Rats dosed with cyproterone acetate and testosterone, were fed at the same time with either PEITC or vehicle control."( Modulating testosterone stimulated prostate growth by phenethyl isothiocyanate via Sp1 and androgen receptor down-regulation.
Beklemisheva, AA; Chiao, JW; Feng, J; Wang, LG; Yeh, YA, 2007
)
0.59
" The maternial body weight gain and the number of implanted and live fetuses were decreased with the increase of PEITC dosage given during pre-implantation period."( [Effect of phenethyl isothiocyanate given at different duration of gestation on the outcome of pregnancy in rats].
Geng, G; Liu, H; Xu, H; Yu, Z; Zhi, Y, 2011
)
0.76
" The TKTD model was better suited to interpret the survival data than descriptive dose-response analysis (LC(x)), accounting for the fast dissipation of the compounds in the soil."( Time-related survival effects of two gluconasturtiin hydrolysis products on the terrestrial isopod Porcellio scaber.
Ellers, J; Hansen, M; Jager, T; Krommenhoek, T; Roelofs, D; Styrishave, B; van Gestel, CA; van Ommen Kloeke, AE; van Pomeren, M, 2012
)
0.38
" No evident dose-response relationship between cellular ROS level and cytotoxicity was observed."( No evident dose-response relationship between cellular ROS level and its cytotoxicity--a paradoxical issue in ROS-based cancer therapy.
Hu, W; Hu, X; Wu, H; Zhu, C, 2014
)
0.4
" Surprisingly, oral dosing of both compounds suppressed scratching behaviors that were observed in mice."( Anti-pruritic effect of isothiocyanates: Potential involvement of toll-like receptor 3 signaling.
Hayashi, I; Kainoh, M; Konno, M; Majima, Y; Moriyama, M; Serizawa, K; Suzuki, T; Yuzawa, N, 2022
)
0.72
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitorAn EC 1.2.1.* (oxidoreductase acting on donor aldehyde/oxo group with NAD(+) or NADP(+) as acceptor) inhibitor that interferes with the action of aldehyde dehydrogenase (NAD(+)), EC 1.2.1.3.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
isothiocyanateAn organosulfur compound with the general formula R-N=C=S.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (39)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency40.01260.007215.758889.3584AID1224835
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency55.06203.189029.884159.4836AID1224846
RAR-related orphan receptor gammaMus musculus (house mouse)Potency24.13870.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency61.25490.000714.592883.7951AID1259368
AR proteinHomo sapiens (human)Potency49.73550.000221.22318,912.5098AID1259243; AID1259247; AID743036; AID743053
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency30.70020.000657.913322,387.1992AID1259378
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency6.87570.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency19.37050.000417.946075.1148AID1346795
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency55.06200.000214.376460.0339AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency19.48410.003041.611522,387.1992AID1159552; AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency58.42130.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency35.84980.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
farnesoid X nuclear receptorHomo sapiens (human)Potency55.06200.375827.485161.6524AID743217
pregnane X nuclear receptorHomo sapiens (human)Potency54.59350.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency46.55650.000229.305416,493.5996AID1259244; AID1259248; AID1259383; AID743069; AID743075; AID743079; AID743080; AID743091
aryl hydrocarbon receptorHomo sapiens (human)Potency55.66140.000723.06741,258.9301AID743085; AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency9.70830.001723.839378.1014AID743083
thyrotropin-releasing hormone receptorHomo sapiens (human)Potency30.21380.154917.870243.6557AID1346877
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency55.062019.739145.978464.9432AID1159509
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency51.03100.057821.109761.2679AID1159526; AID1159528
Histone H2A.xCricetulus griseus (Chinese hamster)Potency127.10200.039147.5451146.8240AID1224845; AID1224896
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency68.72910.000323.4451159.6830AID743065; AID743067
heat shock protein beta-1Homo sapiens (human)Potency17.12380.042027.378961.6448AID743210; AID743228
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency77.11540.000627.21521,122.0200AID743202
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency27.36160.001557.789015,848.9004AID1259244
Cellular tumor antigen p53Homo sapiens (human)Potency15.38650.002319.595674.0614AID651631
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency27.36160.001551.739315,848.9004AID1259244
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency68.72910.011917.942071.5630AID651632
Ataxin-2Homo sapiens (human)Potency68.72910.011912.222168.7989AID651632
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cytochrome P450 2E1Homo sapiens (human)Ki10.49009.98009.98009.9800AID1212090; AID589103
Replicase polyprotein 1abSevere acute respiratory syndrome-related coronavirusIC50 (µMol)10.13000.00402.92669.9600AID1805801
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2IC50 (µMol)10.13000.00022.45859.9600AID1805801
Cytochrome P450 2A6Homo sapiens (human)Ki1.70000.00561.52717.5000AID1209284
Macrophage migration inhibitory factorHomo sapiens (human)IC50 (µMol)8.80000.03803.09109.8000AID1198787; AID1198788
Hypoxia-inducible factor 1-alphaHomo sapiens (human)IC50 (µMol)7.50000.00072.46529.2100AID716167
Cytochrome P450 2A13Homo sapiens (human)Ki3.80000.04002.71005.6000AID1209283
Endothelial PAS domain-containing protein 1Homo sapiens (human)IC50 (µMol)7.50000.00302.60028.5100AID716167
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transient receptor potential cation channel subfamily A member 1Homo sapiens (human)EC50 (µMol)5.18500.00033.166210.0000AID1235910; AID482142
Cytochrome P450 2A6Homo sapiens (human)Kd6.20000.68003.19506.2000AID1209278
Cytochrome P450 2A13Homo sapiens (human)Kd0.43000.43003.18008.2000AID1209287
Transient receptor potential cation channel subfamily V member 1Homo sapiens (human)EC50 (µMol)180.00000.00051.06746.3096AID1235912
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (319)

Processvia Protein(s)Taxonomy
monoatomic ion transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellular calcium ion homeostasisTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cell surface receptor signaling pathwayTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to coldTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to xenobiotic stimulusTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic cyclic compoundTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
protein homotetramerizationTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to hydrogen peroxideTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
long-chain fatty acid metabolic processCytochrome P450 2E1Homo sapiens (human)
lipid hydroxylationCytochrome P450 2E1Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2E1Homo sapiens (human)
steroid metabolic processCytochrome P450 2E1Homo sapiens (human)
response to bacteriumCytochrome P450 2E1Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2E1Homo sapiens (human)
carbon tetrachloride metabolic processCytochrome P450 2E1Homo sapiens (human)
benzene metabolic processCytochrome P450 2E1Homo sapiens (human)
4-nitrophenol metabolic processCytochrome P450 2E1Homo sapiens (human)
halogenated hydrocarbon metabolic processCytochrome P450 2E1Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 2E1Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2E1Homo sapiens (human)
symbiont-mediated perturbation of host ubiquitin-like protein modificationReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
xenobiotic metabolic processCytochrome P450 2A6Homo sapiens (human)
steroid metabolic processCytochrome P450 2A6Homo sapiens (human)
coumarin metabolic processCytochrome P450 2A6Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2A6Homo sapiens (human)
coumarin catabolic processCytochrome P450 2A6Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2A6Homo sapiens (human)
prostaglandin biosynthetic processMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of cytokine productionMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of mature B cell apoptotic processMacrophage migration inhibitory factorHomo sapiens (human)
inflammatory responseMacrophage migration inhibitory factorHomo sapiens (human)
cell surface receptor signaling pathwayMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of cell population proliferationMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of gene expressionMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of protein kinase A signalingMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of macrophage chemotaxisMacrophage migration inhibitory factorHomo sapiens (human)
carboxylic acid metabolic processMacrophage migration inhibitory factorHomo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of cell migrationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of B cell proliferationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of lipopolysaccharide-mediated signaling pathwayMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of tumor necrosis factor productionMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of myeloid cell apoptotic processMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of phosphorylationMacrophage migration inhibitory factorHomo sapiens (human)
regulation of macrophage activationMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of apoptotic processMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of DNA damage response, signal transduction by p53 class mediatorMacrophage migration inhibitory factorHomo sapiens (human)
innate immune responseMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of fibroblast proliferationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationMacrophage migration inhibitory factorHomo sapiens (human)
positive chemotaxisMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of protein metabolic processMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of prostaglandin secretion involved in immune responseMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of myeloid leukocyte cytokine production involved in immune responseMacrophage migration inhibitory factorHomo sapiens (human)
protein homotrimerizationMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of arachidonic acid secretionMacrophage migration inhibitory factorHomo sapiens (human)
cellular senescenceMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of chemokine (C-X-C motif) ligand 2 productionMacrophage migration inhibitory factorHomo sapiens (human)
negative regulation of cellular senescenceMacrophage migration inhibitory factorHomo sapiens (human)
positive regulation of chemokine-mediated signaling pathwayHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of signaling receptor activityHypoxia-inducible factor 1-alphaHomo sapiens (human)
response to hypoxiaHypoxia-inducible factor 1-alphaHomo sapiens (human)
regulation of DNA-templated transcriptionHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIHypoxia-inducible factor 1-alphaHomo sapiens (human)
response to reactive oxygen speciesHypoxia-inducible factor 1-alphaHomo sapiens (human)
angiogenesisHypoxia-inducible factor 1-alphaHomo sapiens (human)
response to hypoxiaHypoxia-inducible factor 1-alphaHomo sapiens (human)
intracellular glucose homeostasisHypoxia-inducible factor 1-alphaHomo sapiens (human)
neural crest cell migrationHypoxia-inducible factor 1-alphaHomo sapiens (human)
epithelial to mesenchymal transitionHypoxia-inducible factor 1-alphaHomo sapiens (human)
embryonic placenta developmentHypoxia-inducible factor 1-alphaHomo sapiens (human)
B-1 B cell homeostasisHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of endothelial cell proliferationHypoxia-inducible factor 1-alphaHomo sapiens (human)
heart loopingHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of neuroblast proliferationHypoxia-inducible factor 1-alphaHomo sapiens (human)
chondrocyte differentiationHypoxia-inducible factor 1-alphaHomo sapiens (human)
glandular epithelial cell maturationHypoxia-inducible factor 1-alphaHomo sapiens (human)
connective tissue replacement involved in inflammatory response wound healingHypoxia-inducible factor 1-alphaHomo sapiens (human)
outflow tract morphogenesisHypoxia-inducible factor 1-alphaHomo sapiens (human)
cardiac ventricle morphogenesisHypoxia-inducible factor 1-alphaHomo sapiens (human)
lactate metabolic processHypoxia-inducible factor 1-alphaHomo sapiens (human)
regulation of glycolytic processHypoxia-inducible factor 1-alphaHomo sapiens (human)
regulation of DNA-templated transcriptionHypoxia-inducible factor 1-alphaHomo sapiens (human)
intracellular iron ion homeostasisHypoxia-inducible factor 1-alphaHomo sapiens (human)
signal transductionHypoxia-inducible factor 1-alphaHomo sapiens (human)
neuroblast proliferationHypoxia-inducible factor 1-alphaHomo sapiens (human)
lactationHypoxia-inducible factor 1-alphaHomo sapiens (human)
visual learningHypoxia-inducible factor 1-alphaHomo sapiens (human)
response to iron ionHypoxia-inducible factor 1-alphaHomo sapiens (human)
regulation of gene expressionHypoxia-inducible factor 1-alphaHomo sapiens (human)
vascular endothelial growth factor productionHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of vascular endothelial growth factor productionHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of gene expressionHypoxia-inducible factor 1-alphaHomo sapiens (human)
negative regulation of gene expressionHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of epithelial cell migrationHypoxia-inducible factor 1-alphaHomo sapiens (human)
response to muscle activityHypoxia-inducible factor 1-alphaHomo sapiens (human)
axonal transport of mitochondrionHypoxia-inducible factor 1-alphaHomo sapiens (human)
neural fold elevation formationHypoxia-inducible factor 1-alphaHomo sapiens (human)
cerebral cortex developmentHypoxia-inducible factor 1-alphaHomo sapiens (human)
bone mineralizationHypoxia-inducible factor 1-alphaHomo sapiens (human)
negative regulation of bone mineralizationHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of vascular endothelial growth factor receptor signaling pathwayHypoxia-inducible factor 1-alphaHomo sapiens (human)
TOR signalingHypoxia-inducible factor 1-alphaHomo sapiens (human)
negative regulation of TOR signalingHypoxia-inducible factor 1-alphaHomo sapiens (human)
intracellular oxygen homeostasisHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of chemokine productionHypoxia-inducible factor 1-alphaHomo sapiens (human)
regulation of transforming growth factor beta2 productionHypoxia-inducible factor 1-alphaHomo sapiens (human)
collagen metabolic processHypoxia-inducible factor 1-alphaHomo sapiens (human)
cellular response to oxidative stressHypoxia-inducible factor 1-alphaHomo sapiens (human)
embryonic hemopoiesisHypoxia-inducible factor 1-alphaHomo sapiens (human)
insulin secretion involved in cellular response to glucose stimulusHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of insulin secretion involved in cellular response to glucose stimulusHypoxia-inducible factor 1-alphaHomo sapiens (human)
hemoglobin biosynthetic processHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of blood vessel endothelial cell migrationHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of erythrocyte differentiationHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of angiogenesisHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of DNA-templated transcriptionHypoxia-inducible factor 1-alphaHomo sapiens (human)
negative regulation of growthHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIHypoxia-inducible factor 1-alphaHomo sapiens (human)
muscle cell cellular homeostasisHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of hormone biosynthetic processHypoxia-inducible factor 1-alphaHomo sapiens (human)
digestive tract morphogenesisHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of nitric-oxide synthase activityHypoxia-inducible factor 1-alphaHomo sapiens (human)
neuron apoptotic processHypoxia-inducible factor 1-alphaHomo sapiens (human)
elastin metabolic processHypoxia-inducible factor 1-alphaHomo sapiens (human)
intestinal epithelial cell maturationHypoxia-inducible factor 1-alphaHomo sapiens (human)
epithelial cell differentiation involved in mammary gland alveolus developmentHypoxia-inducible factor 1-alphaHomo sapiens (human)
iris morphogenesisHypoxia-inducible factor 1-alphaHomo sapiens (human)
retina vasculature development in camera-type eyeHypoxia-inducible factor 1-alphaHomo sapiens (human)
negative regulation of thymocyte apoptotic processHypoxia-inducible factor 1-alphaHomo sapiens (human)
cellular response to interleukin-1Hypoxia-inducible factor 1-alphaHomo sapiens (human)
cellular response to hypoxiaHypoxia-inducible factor 1-alphaHomo sapiens (human)
dopaminergic neuron differentiationHypoxia-inducible factor 1-alphaHomo sapiens (human)
mesenchymal cell apoptotic processHypoxia-inducible factor 1-alphaHomo sapiens (human)
hypoxia-inducible factor-1alpha signaling pathwayHypoxia-inducible factor 1-alphaHomo sapiens (human)
cellular response to virusHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of cytokine production involved in inflammatory responseHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of mitophagyHypoxia-inducible factor 1-alphaHomo sapiens (human)
negative regulation of miRNA transcriptionHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of miRNA transcriptionHypoxia-inducible factor 1-alphaHomo sapiens (human)
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathwayHypoxia-inducible factor 1-alphaHomo sapiens (human)
regulation of aerobic respirationHypoxia-inducible factor 1-alphaHomo sapiens (human)
negative regulation of reactive oxygen species metabolic processHypoxia-inducible factor 1-alphaHomo sapiens (human)
regulation of protein neddylationHypoxia-inducible factor 1-alphaHomo sapiens (human)
negative regulation of mesenchymal cell apoptotic processHypoxia-inducible factor 1-alphaHomo sapiens (human)
regulation of transcription by RNA polymerase IIHypoxia-inducible factor 1-alphaHomo sapiens (human)
coumarin metabolic processCytochrome P450 2A13Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 2A13Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2A13Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2A13Homo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IITransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
fever generationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
microglial cell activationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
diet induced thermogenesisTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
peptide secretionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of systemic arterial blood pressureTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
lipid metabolic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cell surface receptor signaling pathwayTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
chemosensory behaviorTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of heart rateTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of mitochondrial membrane potentialTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
glutamate secretionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to heatTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of apoptotic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
response to peptide hormoneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of nitric oxide biosynthetic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
behavioral response to painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
sensory perception of mechanical stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of temperature stimulus involved in thermoceptionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of temperature stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
protein homotetramerizationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
excitatory postsynaptic potentialTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
smooth muscle contraction involved in micturitionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to alkaloidTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to ATPTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to tumor necrosis factorTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to acidic pHTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to temperature stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of establishment of blood-brain barrierTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium ion import across plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
response to capsazepineTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to nerve growth factor stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
response to hypoxiaEndothelial PAS domain-containing protein 1Homo sapiens (human)
angiogenesisEndothelial PAS domain-containing protein 1Homo sapiens (human)
embryonic placenta developmentEndothelial PAS domain-containing protein 1Homo sapiens (human)
blood vessel remodelingEndothelial PAS domain-containing protein 1Homo sapiens (human)
regulation of heart rateEndothelial PAS domain-containing protein 1Homo sapiens (human)
epithelial cell maturationEndothelial PAS domain-containing protein 1Homo sapiens (human)
response to oxidative stressEndothelial PAS domain-containing protein 1Homo sapiens (human)
mitochondrion organizationEndothelial PAS domain-containing protein 1Homo sapiens (human)
signal transductionEndothelial PAS domain-containing protein 1Homo sapiens (human)
visual perceptionEndothelial PAS domain-containing protein 1Homo sapiens (human)
erythrocyte differentiationEndothelial PAS domain-containing protein 1Homo sapiens (human)
lung developmentEndothelial PAS domain-containing protein 1Homo sapiens (human)
norepinephrine metabolic processEndothelial PAS domain-containing protein 1Homo sapiens (human)
mRNA transcription by RNA polymerase IIEndothelial PAS domain-containing protein 1Homo sapiens (human)
surfactant homeostasisEndothelial PAS domain-containing protein 1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIEndothelial PAS domain-containing protein 1Homo sapiens (human)
myoblast fate commitmentEndothelial PAS domain-containing protein 1Homo sapiens (human)
multicellular organismal-level iron ion homeostasisEndothelial PAS domain-containing protein 1Homo sapiens (human)
cellular response to hypoxiaEndothelial PAS domain-containing protein 1Homo sapiens (human)
positive regulation of cold-induced thermogenesisEndothelial PAS domain-containing protein 1Homo sapiens (human)
regulation of protein neddylationEndothelial PAS domain-containing protein 1Homo sapiens (human)
regulation of transcription by RNA polymerase IIEndothelial PAS domain-containing protein 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (95)

Processvia Protein(s)Taxonomy
calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellularly gated calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
temperature-gated cation channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
monooxygenase activityCytochrome P450 2E1Homo sapiens (human)
iron ion bindingCytochrome P450 2E1Homo sapiens (human)
oxidoreductase activityCytochrome P450 2E1Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygenCytochrome P450 2E1Homo sapiens (human)
4-nitrophenol 2-monooxygenase activityCytochrome P450 2E1Homo sapiens (human)
oxygen bindingCytochrome P450 2E1Homo sapiens (human)
enzyme bindingCytochrome P450 2E1Homo sapiens (human)
heme bindingCytochrome P450 2E1Homo sapiens (human)
Hsp70 protein bindingCytochrome P450 2E1Homo sapiens (human)
Hsp90 protein bindingCytochrome P450 2E1Homo sapiens (human)
aromatase activityCytochrome P450 2E1Homo sapiens (human)
long-chain fatty acid omega-1 hydroxylase activityCytochrome P450 2E1Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2E1Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2E1Homo sapiens (human)
3'-5'-RNA exonuclease activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
RNA-dependent RNA polymerase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
cysteine-type endopeptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
mRNA 5'-cap (guanine-N7-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
mRNA (nucleoside-2'-O-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
5'-3' RNA helicase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
K63-linked deubiquitinase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
K48-linked deubiquitinase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
3'-5'-RNA exonuclease activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
RNA-dependent RNA polymerase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
cysteine-type endopeptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA 5'-cap (guanine-N7-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA (nucleoside-2'-O-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA guanylyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
RNA endonuclease activity, producing 3'-phosphomonoestersReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
ISG15-specific peptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
5'-3' RNA helicase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
protein guanylyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
iron ion bindingCytochrome P450 2A6Homo sapiens (human)
coumarin 7-hydroxylase activityCytochrome P450 2A6Homo sapiens (human)
enzyme bindingCytochrome P450 2A6Homo sapiens (human)
heme bindingCytochrome P450 2A6Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2A6Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2A6Homo sapiens (human)
protease bindingMacrophage migration inhibitory factorHomo sapiens (human)
dopachrome isomerase activityMacrophage migration inhibitory factorHomo sapiens (human)
cytokine activityMacrophage migration inhibitory factorHomo sapiens (human)
cytokine receptor bindingMacrophage migration inhibitory factorHomo sapiens (human)
protein bindingMacrophage migration inhibitory factorHomo sapiens (human)
chemoattractant activityMacrophage migration inhibitory factorHomo sapiens (human)
identical protein bindingMacrophage migration inhibitory factorHomo sapiens (human)
phenylpyruvate tautomerase activityMacrophage migration inhibitory factorHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificHypoxia-inducible factor 1-alphaHomo sapiens (human)
sequence-specific DNA bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
RNA polymerase II transcription regulatory region sequence-specific DNA bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificHypoxia-inducible factor 1-alphaHomo sapiens (human)
cis-regulatory region sequence-specific DNA bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
DNA-binding transcription activator activityHypoxia-inducible factor 1-alphaHomo sapiens (human)
DNA-binding transcription repressor activityHypoxia-inducible factor 1-alphaHomo sapiens (human)
transcription coactivator bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificHypoxia-inducible factor 1-alphaHomo sapiens (human)
p53 bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
DNA-binding transcription factor activityHypoxia-inducible factor 1-alphaHomo sapiens (human)
protein bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
nuclear receptor bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
enzyme bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
protein kinase bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
protein domain specific bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
ubiquitin protein ligase bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
histone deacetylase bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
protein heterodimerization activityHypoxia-inducible factor 1-alphaHomo sapiens (human)
Hsp90 protein bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
E-box bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
transcription regulator activator activityHypoxia-inducible factor 1-alphaHomo sapiens (human)
monooxygenase activityCytochrome P450 2A13Homo sapiens (human)
iron ion bindingCytochrome P450 2A13Homo sapiens (human)
coumarin 7-hydroxylase activityCytochrome P450 2A13Homo sapiens (human)
heme bindingCytochrome P450 2A13Homo sapiens (human)
aromatase activityCytochrome P450 2A13Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2A13Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2A13Homo sapiens (human)
transmembrane signaling receptor activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
extracellular ligand-gated monoatomic ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
excitatory extracellular ligand-gated monoatomic ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
voltage-gated calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
protein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calmodulin bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
ATP bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
intracellularly gated calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
chloride channel regulator activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
phosphatidylinositol bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
metal ion bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
phosphoprotein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
temperature-gated ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
sequence-specific DNA bindingEndothelial PAS domain-containing protein 1Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingEndothelial PAS domain-containing protein 1Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificEndothelial PAS domain-containing protein 1Homo sapiens (human)
transcription coactivator bindingEndothelial PAS domain-containing protein 1Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificEndothelial PAS domain-containing protein 1Homo sapiens (human)
protein bindingEndothelial PAS domain-containing protein 1Homo sapiens (human)
protein heterodimerization activityEndothelial PAS domain-containing protein 1Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingEndothelial PAS domain-containing protein 1Homo sapiens (human)
RNA polymerase II transcription regulatory region sequence-specific DNA bindingEndothelial PAS domain-containing protein 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (49)

Processvia Protein(s)Taxonomy
plasma membraneTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
stereocilium bundleTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
mitochondrial inner membraneCytochrome P450 2E1Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2E1Homo sapiens (human)
cytoplasmCytochrome P450 2E1Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2E1Homo sapiens (human)
double membrane vesicle viral factory outer membraneReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
double membrane vesicle viral factory outer membraneReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
endoplasmic reticulum membraneCytochrome P450 2A6Homo sapiens (human)
cytoplasmic microtubuleCytochrome P450 2A6Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2A6Homo sapiens (human)
cytoplasmCytochrome P450 2A6Homo sapiens (human)
extracellular regionMacrophage migration inhibitory factorHomo sapiens (human)
extracellular spaceMacrophage migration inhibitory factorHomo sapiens (human)
nucleoplasmMacrophage migration inhibitory factorHomo sapiens (human)
cytoplasmMacrophage migration inhibitory factorHomo sapiens (human)
cytosolMacrophage migration inhibitory factorHomo sapiens (human)
plasma membraneMacrophage migration inhibitory factorHomo sapiens (human)
cell surfaceMacrophage migration inhibitory factorHomo sapiens (human)
vesicleMacrophage migration inhibitory factorHomo sapiens (human)
secretory granule lumenMacrophage migration inhibitory factorHomo sapiens (human)
extracellular exosomeMacrophage migration inhibitory factorHomo sapiens (human)
ficolin-1-rich granule lumenMacrophage migration inhibitory factorHomo sapiens (human)
extracellular spaceMacrophage migration inhibitory factorHomo sapiens (human)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
nucleusHypoxia-inducible factor 1-alphaHomo sapiens (human)
nucleoplasmHypoxia-inducible factor 1-alphaHomo sapiens (human)
cytoplasmHypoxia-inducible factor 1-alphaHomo sapiens (human)
cytosolHypoxia-inducible factor 1-alphaHomo sapiens (human)
nuclear bodyHypoxia-inducible factor 1-alphaHomo sapiens (human)
nuclear speckHypoxia-inducible factor 1-alphaHomo sapiens (human)
motile ciliumHypoxia-inducible factor 1-alphaHomo sapiens (human)
axon cytoplasmHypoxia-inducible factor 1-alphaHomo sapiens (human)
chromatinHypoxia-inducible factor 1-alphaHomo sapiens (human)
euchromatinHypoxia-inducible factor 1-alphaHomo sapiens (human)
protein-containing complexHypoxia-inducible factor 1-alphaHomo sapiens (human)
RNA polymerase II transcription regulator complexHypoxia-inducible factor 1-alphaHomo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2A13Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2A13Homo sapiens (human)
cytoplasmCytochrome P450 2A13Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
external side of plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
dendritic spine membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
neuronal cell bodyTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
postsynaptic membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
nucleoplasmEndothelial PAS domain-containing protein 1Homo sapiens (human)
cytosolEndothelial PAS domain-containing protein 1Homo sapiens (human)
nuclear speckEndothelial PAS domain-containing protein 1Homo sapiens (human)
chromatinEndothelial PAS domain-containing protein 1Homo sapiens (human)
transcription regulator complexEndothelial PAS domain-containing protein 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (192)

Assay IDTitleYearJournalArticle
AID1235914Activation of human TRPV1 expressed in TREx-HEK cells at 300 uM by Fluo-4 AM dye-based Ca2+ imaging assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID1212092Inhibition of human CYP2E1 expressed in Escherichia coli MV1304 assessed as reduction in 7-EFC O-de-ethylation activity in absence of cytochrome b5 by spectrofluorometry2013Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
The inactivation of human CYP2E1 by phenethyl isothiocyanate, a naturally occurring chemopreventive agent, and its oxidative bioactivation.
AID611168Cell cycle arrest in human A549 cells assessed as accumulation at G2/M phase at 10 uM after 24 hrs using propidium iodide staining by flow cytometry (Rvb = 14.5 +/- 1.2 %)2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Synthesis and antiproliferative activity of novel α- and β-dialkoxyphosphoryl isothiocyanates.
AID1105125Fungistatic activity in Sclerotinia sclerotiorum assessed as sclerotial viability measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID716160Inhibition of mTORC1 in p53-/-TSC+/+ MEF cells assessed as reduction of p70S6K phosphorylation after 3 hrs by immunoblotting analysis2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2.
AID692248Induction of p53 depletion in human MCF7 cells at 20 uM incubated for 2 to 24 hrs by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID692155Effect on Bax protein expression in human NCI-H596 cells by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID412933Antiproliferative activity against human UACC-903 cells assessed as BrdU incorporation after 24 hrs by ELISA relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates.
AID1212098Inactivation of human CYP2E1 expressed in Escherichia coli MV1304 assessed as remaining enzyme activity at 25 uM in presence of 1.2 mM NADPH after dialysis by 7-EFC O-de-ethylation activity detection based spectrofluorometry2013Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
The inactivation of human CYP2E1 by phenethyl isothiocyanate, a naturally occurring chemopreventive agent, and its oxidative bioactivation.
AID1212090Inhibition of human CYP2E1 expressed in Escherichia coli MV1304 assessed as reduction in 7-EFC O-de-ethylation activity by spectrofluorometry based double reciprocal plot2013Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
The inactivation of human CYP2E1 by phenethyl isothiocyanate, a naturally occurring chemopreventive agent, and its oxidative bioactivation.
AID1574489Inhibition of recombinant His6-tagged USP7 catalytic domain (unknown origin) assessed as association constant using Ub-AMC as substrate by fluorescence assay2019Bioorganic & medicinal chemistry letters, 01-15, Volume: 29, Issue:2
Diarylcarbonates are a new class of deubiquitinating enzyme inhibitor.
AID692257Induction of covalent cysteine modification at p53 G245C mutant in human NCI-H596 cells at 100 uM incubated for 1 hr by monochlorobimane fluorometric assay2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID692160Effect on JNK protein expression in human NCI-H596 cells by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID436146Antiproliferative activity against human OVCAR-3 cells2008Journal of natural products, Nov, Volume: 71, Issue:11
Sulforaphane induces cell-cycle arrest and apoptosis in cultured human lung adenocarcinoma LTEP-A2 cells and retards growth of LTEP-A2 xenografts in vivo.
AID611259Cell cycle arrest in human A549 cells assessed as accumulation at sub G0/G1 phase at 10 uM after 72 hrs using propidium iodide staining by flow cytometry (Rvb = 7.5 +/- 1.3 %)2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Synthesis and antiproliferative activity of novel α- and β-dialkoxyphosphoryl isothiocyanates.
AID436150Antiproliferative activity against human LTEP-A2 cells after 24 hrs by trypan blue exclusion assay2008Journal of natural products, Nov, Volume: 71, Issue:11
Sulforaphane induces cell-cycle arrest and apoptosis in cultured human lung adenocarcinoma LTEP-A2 cells and retards growth of LTEP-A2 xenografts in vivo.
AID1212095Inactivation of human CYP2E1 expressed in Escherichia coli MV1304 assessed as remaining enzyme activity at 25 uM after dialysis in presence of fresh reductase by 7-EFC O-de-ethylation activity detection based spectrofluorometry2013Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
The inactivation of human CYP2E1 by phenethyl isothiocyanate, a naturally occurring chemopreventive agent, and its oxidative bioactivation.
AID715956Inhibition of growth in TSC2-deficient MEF cells after 6 days2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2.
AID692255Induction of p53 G245C mutant depletion in human NCI-H596 cells at 20 uM by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID692253Induction of non-temperature sensitive p53 175H mutant depletion in human H1299 cells at 15 uM incubated for 24 hrs at 37 degC by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID692263Induction of apoptosis in human MDA-MB-468 cells expressing p53 R273H mutant assessed as caspase-3 activation incubated for 24 hrs2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID1816770Induction of apoptosis in human MCF7 cells expressing wild type p53 assessed as decrease in level of uncleaved PARP1 level at 6 to 12 uM measured after 24 hrs by western blotting analysis2021Journal of medicinal chemistry, 05-27, Volume: 64, Issue:10
Adamantyl Isothiocyanates as Mutant p53 Rescuing Agents and Their Structure-Activity Relationships.
AID589103Mechanism based inhibition of human cytochrome P450 2E12005Current drug metabolism, Oct, Volume: 6, Issue:5
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
AID699541Inhibition of human liver OATP2B1 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E3S uptake at 20 uM incubated for 5 mins by scintillation counting2012Journal of medicinal chemistry, May-24, Volume: 55, Issue:10
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
AID611258Cell cycle arrest in human A549 cells assessed as accumulation at G2/M phase at 10 uM after 72 hrs using propidium iodide staining by flow cytometry (Rvb = 12.5 +/- 1.7 %)2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Synthesis and antiproliferative activity of novel α- and β-dialkoxyphosphoryl isothiocyanates.
AID611261Cell cycle arrest in human A549 cells assessed as ratio of accumulation of cells at G0/G1 phase to S phase at 10 uM after 48 hrs using propidium iodide staining by flow cytometry (Rvb = 3.8%)2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Synthesis and antiproliferative activity of novel α- and β-dialkoxyphosphoryl isothiocyanates.
AID1209287Binding affinity to CYP2A13 (unknown origin) assessed as type 1 interaction as increase in absorbance 379 to 387 nm and decrease in 414 to 420 nm2012Drug metabolism and disposition: the biological fate of chemicals, Sep, Volume: 40, Issue:9
Evaluation of inhibition selectivity for human cytochrome P450 2A enzymes.
AID1235917Agonist activity at mouse TRPM8 expressed in TREx-HEK cells at 300 uM by Fluo-4 AM dye-based Ca2+ imaging assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID611172Cell cycle arrest in human A549 cells assessed as accumulation at S phase at 10 uM after 48 hrs using propidium iodide staining by flow cytometry (Rvb = 17 +/- 0.3 %)2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Synthesis and antiproliferative activity of novel α- and β-dialkoxyphosphoryl isothiocyanates.
AID716166Inhibition of Serine/threonine-protein kinase mTOR complex 1-mediated HIF1alpha RNA translation in human MCF7 cells at 20 uM pretreated for 1 hr prior to metabolic labeling by SDS-PAGE analysis2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2.
AID716153Inhibition of mTORC1 in p53-/-TSC2+/+ MEF cells assessed as reduction of p70S6K phosphorylation at threonine 389 after 3 hrs by immunoblotting analysis2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2.
AID1212101Inactivation of human CYP2E1 expressed in Escherichia coli MV1304 assessed as remaining heme level at 25 uM in presence of 1.2 mM NADPH after dialysis by HPLC method2013Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
The inactivation of human CYP2E1 by phenethyl isothiocyanate, a naturally occurring chemopreventive agent, and its oxidative bioactivation.
AID1235915Activation of human TRPV1 expressed in TREx-HEK cells at 300 uM in presence of TRPV1 antagonist CPZ by Fluo-4 AM dye-based Ca2+ imaging assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID1212089Inhibition of human CYP2E1 expressed in Escherichia coli MV1304 assessed as reduction in 7-EFC O-de-ethylation activity by spectrofluorometry2013Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
The inactivation of human CYP2E1 by phenethyl isothiocyanate, a naturally occurring chemopreventive agent, and its oxidative bioactivation.
AID716162Inhibition of mTORC1 in human MCF7 cells assessed as reduction of p70S6K phosphorylation at 20 uM after 15 mins by immunoblotting analysis2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2.
AID1816771Induction of apoptosis in human MCF7 cells expressing wild type p53 assessed as increase in cleaved PARP1 level at 6 to 12 uM measured after 24 hrs by western blotting analysis2021Journal of medicinal chemistry, 05-27, Volume: 64, Issue:10
Adamantyl Isothiocyanates as Mutant p53 Rescuing Agents and Their Structure-Activity Relationships.
AID692161Effect on p53 mRNA expression in human NCI-H596 cells at 15 uM incubated for 2 to 6 hrs by RT-PCR2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID1212114Drug metabolism in human liver microsomes assessed as phenethyl isocyanate-GSH formation at 50 uM after 30 mins by ESI LC-MS/MS method2013Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
The inactivation of human CYP2E1 by phenethyl isothiocyanate, a naturally occurring chemopreventive agent, and its oxidative bioactivation.
AID692156Induction of p53 G245C mutant depletion in human NCI-H596 cells incubated for 2 to 6 hrs by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID1105158Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of germination in volatile phase at 67 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID412927Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTS assay2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates.
AID1816799Induction of apoptosis in human MDA-MB-231 cells expressing p53 R280K mutant assessed as increase in level of cleaved PARP1 level at 6 to 12 uM measured after 24 hrs by western blotting analysis2021Journal of medicinal chemistry, 05-27, Volume: 64, Issue:10
Adamantyl Isothiocyanates as Mutant p53 Rescuing Agents and Their Structure-Activity Relationships.
AID412936Antitumor activity in human UACC-903 cells xenografted in Harlan Sprague-Dawley athymic nude mouse assessed as reduction in tumor size at 0.76 uM, ip administered three times per week2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates.
AID1105155Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of germination in volatile phase at 670 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID699539Inhibition of human liver OATP1B1 expressed in HEK293 Flp-In cells assessed as reduction in E17-betaG uptake at 20 uM by scintillation counting2012Journal of medicinal chemistry, May-24, Volume: 55, Issue:10
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
AID1235910Activation of human TRPA1 expressed in TREx-HEK cells by Fluo-4 AM dye-based Ca2+ imaging assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID1212111Covalent binding to human CYP2E1 expressed in Escherichia coli MV1304 assessed as protein-adduct formation at 25 uM in presence of NADPH after 10 mins by ESI LC-MS/MS method2013Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
The inactivation of human CYP2E1 by phenethyl isothiocyanate, a naturally occurring chemopreventive agent, and its oxidative bioactivation.
AID692244Induction of p53 P274L/V223F mutant depletion in human DU145 cells at 10 uM by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID1105099Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of carpogenic germination in volatile phase at 670 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1212116Binding affinity to human CYP2E1 expressed in Escherichia coli MV1304 modification at Cys268 using tryptic digestion and LC-MS/MS method2013Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
The inactivation of human CYP2E1 by phenethyl isothiocyanate, a naturally occurring chemopreventive agent, and its oxidative bioactivation.
AID1816767Induction of apoptosis in human MDA-MB-468 cells expressing p53 R273H mutant assessed as decrease in level of uncleaved caspase 3 level at 6 to 12 uM measured after 24 hrs by western blotting analysis2021Journal of medicinal chemistry, 05-27, Volume: 64, Issue:10
Adamantyl Isothiocyanates as Mutant p53 Rescuing Agents and Their Structure-Activity Relationships.
AID692249Induction of p53 depletion in human MCF10A cells at 15 uM incubated for 2 to 24 hrs by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID412937Antitumor activity in human UACC-903 cells xenografted in Harlan Sprague-Dawley athymic nude mouse assessed as reduction in tumor size at 2.5 uM, ip administered three times per week2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates.
AID1816772Downregulation of p53 R208K mutant expression in human MDA-MB-231 cells at 6 to 12 uM measured after 24 hrs by immunoblot analysis2021Journal of medicinal chemistry, 05-27, Volume: 64, Issue:10
Adamantyl Isothiocyanates as Mutant p53 Rescuing Agents and Their Structure-Activity Relationships.
AID1271567Antiproliferative activity against human LoVo/DX cells assessed as reduction in cell viability after 72 hrs by SRB assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Synthesis and biological activity of diisothiocyanate-derived mercapturic acids.
AID699540Inhibition of human liver OATP1B3 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E17-betaG uptake at 20 uM incubated for 5 mins by scintillation counting2012Journal of medicinal chemistry, May-24, Volume: 55, Issue:10
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
AID692264Induction of apoptosis in human HCT116 cells expressing wild type p53 assessed as caspase-3 activation incubated for 24 hrs2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID1105226Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 67 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1212094Inactivation of human CYP2E1 expressed in Escherichia coli MV1304 assessed as remaining enzyme activity at 25 uM after dialysis by 7-EFC O-de-ethylation activity detection based spectrofluorometry2013Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
The inactivation of human CYP2E1 by phenethyl isothiocyanate, a naturally occurring chemopreventive agent, and its oxidative bioactivation.
AID692254Induction of non-temperature sensitive p53 175H mutant depletion in human H1299 cells at 15 uM incubated for 24 hrs at 32.5 degC by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID1212106Drug metabolism assessed as human CYP2E1-mediated phenethylamine formation at 50 uM in presence of reductase and NADPH after 30 mins by LC-MS/MS method2013Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
The inactivation of human CYP2E1 by phenethyl isothiocyanate, a naturally occurring chemopreventive agent, and its oxidative bioactivation.
AID1212099Inactivation of human CYP2E1 expressed in Escherichia coli MV1304 assessed as remaining enzyme activity at 25 uM in presence of 1.2 mM NADPH after dialysis in presence of fresh reductase by 7-EFC O-de-ethylation activity detection based spectrofluorometry2013Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
The inactivation of human CYP2E1 by phenethyl isothiocyanate, a naturally occurring chemopreventive agent, and its oxidative bioactivation.
AID1105145Fungitoxic activity in Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 469 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1235911Activation of human TRPA1 expressed in TREx-HEK cells by Fluo-4 AM dye-based Ca2+ imaging assay relative to 100 uM ITC2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID1198787Inhibition of human recombinant macrophage migration inhibitory factor tautomerase activity expressed in Escherichia coli DH5alpha using L-dopachrome methyl ester as substrate incubated for 5 mins prior to substrate addition measured for 2 mins by spectro2015European journal of medicinal chemistry, Mar-26, Volume: 93Multiple binding modes of isothiocyanates that inhibit macrophage migration inhibitory factor.
AID1212097Inactivation of human CYP2E1 expressed in Escherichia coli MV1304 assessed as remaining heme level at 25 uM after dialysis by HPLC method2013Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
The inactivation of human CYP2E1 by phenethyl isothiocyanate, a naturally occurring chemopreventive agent, and its oxidative bioactivation.
AID412928Cytotoxicity against human T98G cells after 72 hrs by MTS assay2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates.
AID436141Antiproliferative activity against human LTEP-A2 cells assessed as viable cells at 12.5 uM after 24 hrs by trypan blue exclusion assay2008Journal of natural products, Nov, Volume: 71, Issue:11
Sulforaphane induces cell-cycle arrest and apoptosis in cultured human lung adenocarcinoma LTEP-A2 cells and retards growth of LTEP-A2 xenografts in vivo.
AID1105138Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 2011 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105157Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of germination in volatile phase at 201 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1212100Inactivation of human CYP2E1 expressed in Escherichia coli MV1304 assessed as remaining P450 level at 25 uM in presence of 1.2 mM NADPH after dialysis by CO difference spectral method2013Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
The inactivation of human CYP2E1 by phenethyl isothiocyanate, a naturally occurring chemopreventive agent, and its oxidative bioactivation.
AID404304Effect on human MRP2-mediated estradiol-17-beta-glucuronide transport in Sf9 cells inverted membrane vesicles relative to control2008Journal of medicinal chemistry, Jun-12, Volume: 51, Issue:11
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
AID1105227Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 34 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105087In vivo antifungal Sclerotinia sclerotiorum in Pepper (Capsicum annuum L. cv. Sera Demre) assessed as inhibition of mycelial growth in volatile phase at 134 umol/L measured after 10 to 14 weeks2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1816773Downregulation of p53 R273H mutant expression in human MDA-MB-468 cells at 6 to 12 uM measured after 24 hrs by immunoblot analysis2021Journal of medicinal chemistry, 05-27, Volume: 64, Issue:10
Adamantyl Isothiocyanates as Mutant p53 Rescuing Agents and Their Structure-Activity Relationships.
AID1212107Drug metabolism assessed as human CYP2E1-mediated phenethylamine formation at 50 uM in presence of reductase and absence of NADPH after 30 mins by LC-MS/MS method2013Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
The inactivation of human CYP2E1 by phenethyl isothiocyanate, a naturally occurring chemopreventive agent, and its oxidative bioactivation.
AID692259Induction of apoptosis in human A549 cells expressing wild type p53 assessed as caspase-3 activation incubated for 24 hrs2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID1235904Activation of human TRPA1 expressed in TREx-HEK cells at 1 uM by Fluo-4 AM dye-based Ca2+ imaging assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID611260Cell cycle arrest in human A549 cells assessed as ratio of accumulation of cells at G0/G1 phase to S phase at 10 uM after 24 hrs using propidium iodide staining by flow cytometry (Rvb = 3.5%)2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Synthesis and antiproliferative activity of novel α- and β-dialkoxyphosphoryl isothiocyanates.
AID611171Cell cycle arrest in human A549 cells assessed as accumulation at sug G0/G1 phase at 10 uM after 48 hrs using propidium iodide staining by flow cytometry (Rvb = 6.5 +/- 1.4 %)2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Synthesis and antiproliferative activity of novel α- and β-dialkoxyphosphoryl isothiocyanates.
AID412939Toxicity in human UACC-903 cells xenografted in Harlan Sprague-Dawley athymic nude mouse assessed as effect on body weight at 2.5 uM, ip administered three times per week2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates.
AID716151Effect on mTORC2 in p53-/-TSC2+/+ MEF cells assessed as Akt phosphorylation at serine 473 after 3 hrs by immunoblotting analysis2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2.
AID1816802Upregulation of p53 expression in human MCF7 cells at 6 to 12 uM measured after 24 hrs by immunoblot analysis2021Journal of medicinal chemistry, 05-27, Volume: 64, Issue:10
Adamantyl Isothiocyanates as Mutant p53 Rescuing Agents and Their Structure-Activity Relationships.
AID692243Induction of p53 R273H mutant depletion in human MDA-MB-468 cells at 15 uM by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID716159Inhibition of mTORC1 in MEF cells assessed as reduction of p70S6K phosphorylation at threonine 389 at 2.5 to 5 uM after 3 hrs by immunoblotting analysis2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2.
AID716161Inhibition of mTORC1 in PTEN+/+ MEF cells assessed as reduction of p70S6K phosphorylation after 3 hrs by immunoblotting analysis2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2.
AID1105189Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 670 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1212093Inhibition of human CYP2E1 expressed in Escherichia coli MV1304 assessed as partition ratio for enzyme inactivation2013Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
The inactivation of human CYP2E1 by phenethyl isothiocyanate, a naturally occurring chemopreventive agent, and its oxidative bioactivation.
AID482142Activation of TRPA1 channel2010Journal of medicinal chemistry, Jul-22, Volume: 53, Issue:14
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
AID1235913Activation of human TRPV1 expressed in TREx-HEK cells by Fluo-4 AM dye-based Ca2+ imaging assay relative to 10 uM capsaicin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID1816759Antiproliferative activity against human MCF7 cells expressing WT p53 assessed as inhibition of cell growth at 10 to 50 uM incubated for 24 to 72 hrs by WST-1 assay2021Journal of medicinal chemistry, 05-27, Volume: 64, Issue:10
Adamantyl Isothiocyanates as Mutant p53 Rescuing Agents and Their Structure-Activity Relationships.
AID101367Median toxic concentration of compound tested in vitro against human leukemia 60 cells2000Bioorganic & medicinal chemistry letters, Jan-03, Volume: 10, Issue:1
Antitumour activity of sphingoid base adducts of phenethyl isothiocyanate.
AID1574521Inhibition of recombinant human N-terminal His6-tagged USP9x assessed as association constant using Cy5-UbVME as substrate preincubated for 15 mins followed by substrate addition and measured after 7 mins by fluorescence assay2019Bioorganic & medicinal chemistry letters, 01-15, Volume: 29, Issue:2
Diarylcarbonates are a new class of deubiquitinating enzyme inhibitor.
AID1105192Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 469 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1235916Effect on Ca2+ response in TREx-HEK cells at 300 uM by Fluo-4 AM dye-based Ca2+ imaging assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID1105126Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID476673Cytotoxicity against human HepG2 cells assessed as cell viability at 50 uM after 6 hrs by MTS assay2010Bioorganic & medicinal chemistry letters, Apr-15, Volume: 20, Issue:8
Enhanced Nrf2-dependent induction of glutathione in mouse embryonic fibroblasts by isoselenocyanate analog of sulforaphane.
AID716149Increase in mTORC2 activity in p53-/-TSC2-/- MEF cells assessed as reduction of Akt phosphorylation at serine 473 after 3 hrs by immunoblotting analysis2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2.
AID1105223Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 670 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID412929Cytotoxicity against human PC-3 cells after 72 hrs by MTS assay2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates.
AID1105225Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 335 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID692251Induction of temperature sensitive p53 143A mutant depletion in human H1299 cells at 15 uM incubated for 24 hrs at 37 degC by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID715958Increase in mTORC2 activity in human MCF7 cells induction of Akt phosphorylation at serine 473 after 4 hrs by immunoblotting analysis2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2.
AID716163Inhibition of mTORC1 in human MCF7 cells assessed as reduction of 4E-BP1 phosphorylation after 3 hrs by immunoblotting analysis2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2.
AID1816766Induction of apoptosis in human MDA-MB-231 cells expressing p53 R280K mutant assessed as decrease in level of uncleaved caspase 3 level at 6 to 12 uM measured after 24 hrs by western blotting analysis2021Journal of medicinal chemistry, 05-27, Volume: 64, Issue:10
Adamantyl Isothiocyanates as Mutant p53 Rescuing Agents and Their Structure-Activity Relationships.
AID692265Induction of apoptosis in human SW480 cells expressing p53 R273H mutant assessed as caspase-3 activation incubated for 24 hrs2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID692261Induction of apoptosis in human MCF7 cells expressing wild type p53 assessed as caspase-3 activation incubated for 24 hrs2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID412935Induction of apoptosis in human UACC-903 cells assessed as increase in caspase 7 activity after 24 hrs relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates.
AID611162Antiproliferative activity against doxorubicin-resistant human LoVo cells after 72 hrs by SRB assay2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Synthesis and antiproliferative activity of novel α- and β-dialkoxyphosphoryl isothiocyanates.
AID692239Induction of p53 depletion in human A549 cells at 20 uM incubated for 2 to 24 hrs by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID611158Antiproliferative activity against human A549 cells after 72 hrs by SRB assay2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Synthesis and antiproliferative activity of novel α- and β-dialkoxyphosphoryl isothiocyanates.
AID1209280Ratio of Kd for CYP2A6 (unknown origin) to Kd for CYP2A13 assessed as type 1 interaction as increase in absorbance 379 to 387 nm and decrease in 414 to 420 nm2012Drug metabolism and disposition: the biological fate of chemicals, Sep, Volume: 40, Issue:9
Evaluation of inhibition selectivity for human cytochrome P450 2A enzymes.
AID436142Antiproliferative activity against human LTEP-A2 cells assessed as viable cells at 25 uM after 24 hrs by trypan blue exclusion assay2008Journal of natural products, Nov, Volume: 71, Issue:11
Sulforaphane induces cell-cycle arrest and apoptosis in cultured human lung adenocarcinoma LTEP-A2 cells and retards growth of LTEP-A2 xenografts in vivo.
AID716155Induction of ERK1/2 phosphorylation at threonine 202/tyrosine 204 in human MCF7 cells after 3 hrs by immunoblotting analysis2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2.
AID716148Increase in mTORC2 activity in p53-/-TSC2-/- MEF cells assessed as reduction in NDRG1 phosphorylation at threonine 346 after 3 hrs by immunoblotting analysis2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2.
AID716167Inhibition of Serine/threonine-protein kinase mTOR complex 1-mediated HIF1alpha RNA translation in human MCF7 cells pretreated for 1 hr prior to metabolic labeling by SDS-PAGE analysis2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2.
AID1235912Activation of human TRPV1 expressed in TREx-HEK cells by Fluo-4 AM dye-based Ca2+ imaging assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID1212103Drug metabolism assessed as human CYP2E1-mediated compound-GSH conjugate formation at 50 uM in presence of reductase and NADPH after 30 mins by LC-MS/MS method2013Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
The inactivation of human CYP2E1 by phenethyl isothiocyanate, a naturally occurring chemopreventive agent, and its oxidative bioactivation.
AID611256Cell cycle arrest in human A549 cells assessed as accumulation at G0/G1 phase at 10 uM after 72 hrs using propidium iodide staining by flow cytometry (Rvb = 62 +/- 3.3 %)2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Synthesis and antiproliferative activity of novel α- and β-dialkoxyphosphoryl isothiocyanates.
AID1235908Effect on Ca2+ response in TREx-HEK cells at 1 uM by Fluo-4 AM dye-based Ca2+ imaging assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID1105224Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in volatile phase at 469 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID716154Induction of AMPK phosphorylation at threonine 172 in human MCF7 cells after 3 hrs by immunoblotting analysis2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2.
AID412930Cytotoxicity against human Caco-2 cells after 72 hrs by MTS assay2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates.
AID611159Antiproliferative activity against human T47D cells after 72 hrs by SRB assay2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Synthesis and antiproliferative activity of novel α- and β-dialkoxyphosphoryl isothiocyanates.
AID716150Effect on mTORC2 in p53-/-TSC2+/+ MEF cells assessed as as NDRG1 phosphorylation at threonine 346 after 3 hrs by immunoblotting analysis2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2.
AID1105188Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 2011 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1105191Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 603 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1271566Antiproliferative activity against human LoVo cells assessed as reduction in cell viability after 72 hrs by SRB assay2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Synthesis and biological activity of diisothiocyanate-derived mercapturic acids.
AID412932Cytotoxicity against human UACC-903 cells assessed as decrease in cell viability after 24 hrs by MTS assay relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates.
AID611161Antiproliferative activity against human LoVo cells after 72 hrs by SRB assay2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Synthesis and antiproliferative activity of novel α- and β-dialkoxyphosphoryl isothiocyanates.
AID1105088In vivo antifungal Sclerotinia sclerotiorum in Pepper (Capsicum annuum L. cv. Sera Demre) assessed as inhibition of mycelial growth in volatile phase at 67 umol/L measured after 10 to 14 weeks2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID716157Inhibition of Akt phosphorylation at threonine 308 in human MCF7 cells at 20 uM after 4 hrs by immunoblotting analysis2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2.
AID1105131Fungistatic activity in Sclerotinia sclerotiorum assessed as viability in volatile phase at 335 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID611166Cell cycle arrest in human A549 cells assessed as accumulation at G0/G1 phase at 10 uM after 24 hrs using propidium iodide staining by flow cytometry (Rvb = 62 +/- 2.4 %)2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Synthesis and antiproliferative activity of novel α- and β-dialkoxyphosphoryl isothiocyanates.
AID1105127Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID412934Induction of apoptosis in human UACC-903 cells assessed as increase in caspase 3 activity after 24 hrs relative to control2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates.
AID1212102Inhibition of human CYP2E1 expressed in Escherichia coli MV1304 assessed as reduction in 7-EFC O-de-ethylation activity at 50 uM added 1 min before NADPH addition in presence of 1 mM GSH by spectrofluorometry2013Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
The inactivation of human CYP2E1 by phenethyl isothiocyanate, a naturally occurring chemopreventive agent, and its oxidative bioactivation.
AID412940Cytotoxicity against human HT1080 cells after 72 hrs by MTS assay2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates.
AID1212109Covalent binding to human CYP2E1 expressed in Escherichia coli MV1304 assessed as protein-adduct formation at 25 uM after 10 mins by ESI LC-MS/MS method2013Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
The inactivation of human CYP2E1 by phenethyl isothiocyanate, a naturally occurring chemopreventive agent, and its oxidative bioactivation.
AID611257Cell cycle arrest in human A549 cells assessed as accumulation at S phase at 10 uM after 72 hrs using propidium iodide staining by flow cytometry (Rvb = 16 +/- 2.1 %)2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Synthesis and antiproliferative activity of novel α- and β-dialkoxyphosphoryl isothiocyanates.
AID1105102Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of carpogenic germination in volatile phase at 34 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID611169Cell cycle arrest in human A549 cells assessed as accumulation at sub G0/G1 phase at 10 uM after 24 hrs using propidium iodide staining by flow cytometry (Rvb = 4.5 +/- 1.4 %)2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Synthesis and antiproliferative activity of novel α- and β-dialkoxyphosphoryl isothiocyanates.
AID716156Induction of Akt phosphorylation at threonine 308 in human MCF7 cells after 4 hrs by immunoblotting analysis relative to total Akt2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2.
AID1198788Inhibition of macrophage migration inhibitory factor tautomerase activity in human Jurkat T cells using L-dopachrome methyl ester as substrate incubated for 30 mins prior to substrate addition measured for 2 mins by spectrophotometric analysis2015European journal of medicinal chemistry, Mar-26, Volume: 93Multiple binding modes of isothiocyanates that inhibit macrophage migration inhibitory factor.
AID1105101Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of carpogenic germination in volatile phase at 67 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID716158Inhibition of mTORC1 in PTEN-/- MEF cells assessed as reduction of p70S6K phosphorylation after 3 hrs by immunoblotting analysis2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2.
AID1105190Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of mycelial growth in contact phase at 1340 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID412931Cytotoxicity against human UACC-903 cells after 72 hrs by MTS assay2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates.
AID1209283Mixed inhibition of CYP2A13 (unknown origin)2012Drug metabolism and disposition: the biological fate of chemicals, Sep, Volume: 40, Issue:9
Evaluation of inhibition selectivity for human cytochrome P450 2A enzymes.
AID681336TP_TRANSPORTER: cell accumulation of 0.05u daunomycin in MCF-7/ADR cells2004Journal of pharmaceutical sciences, Jul, Volume: 93, Issue:7
Effects of benzyl-, phenethyl-, and alpha-naphthyl isothiocyanates on P-glycoprotein- and MRP1-mediated transport.
AID716164Inhibition of mTORC1 in human MCF7 cells assessed as reduction of p70S6K phosphorylation at threonine 389 after 3 hrs by immunoblotting analysis2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2.
AID1105100Fungistatic activity in Sclerotinia sclerotiorum assessed as inhibition of carpogenic germination in volatile phase at 335 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID692252Induction of temperature sensitive p53 143A mutant depletion in human H1299 cells at 15 uM incubated for 24 hrs at 32.5 degC by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID611167Cell cycle arrest in human A549 cells assessed as accumulation at S phase at 10 uM after 24 hrs using propidium iodide staining by flow cytometry (Rvb = 18 +/- 1.5%)2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Synthesis and antiproliferative activity of novel α- and β-dialkoxyphosphoryl isothiocyanates.
AID611262Cell cycle arrest in human A549 cells assessed as ratio of accumulation of cells at G0/G1 phase to S phase at 10 uM after 72 hrs using propidium iodide staining by flow cytometry (Rvb = 4.2%)2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Synthesis and antiproliferative activity of novel α- and β-dialkoxyphosphoryl isothiocyanates.
AID692250Induction of p53 activation in human MCF7 cells at 20 uM incubated for 24 hrs by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID692247Induction of p53 depletion in human HCT116 cells at 20 uM incubated for 2 to 24 hrs by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID692246Induction of p53 P151S mutant depletion in human SCC4 cells at 15 uM by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID1105159Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of germination in volatile phase at 34 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1816754Antiproliferative activity against human MDA-MB-231 cells expressing p53 R280K mutant assessed as inhibition of cell growth at 10 to 50 uM incubated for 24 to 72 hrs by WST-1 assay2021Journal of medicinal chemistry, 05-27, Volume: 64, Issue:10
Adamantyl Isothiocyanates as Mutant p53 Rescuing Agents and Their Structure-Activity Relationships.
AID436145Antiproliferative activity against human LS 174T cells2008Journal of natural products, Nov, Volume: 71, Issue:11
Sulforaphane induces cell-cycle arrest and apoptosis in cultured human lung adenocarcinoma LTEP-A2 cells and retards growth of LTEP-A2 xenografts in vivo.
AID692262Induction of apoptosis in human MDA-MB-231 cells expressing p53 R280K mutant assessed as caspase-3 activation incubated for 24 hrs2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID692159Effect on HSP90 protein expression in human NCI-H596 cells by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID1235906Activation of human TRPA1 expressed in TREx-HEK cells at 1 uM in presence of TRPA1 antagonist HC030031 by Fluo-4 AM dye-based Ca2+ imaging assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
AID1105128Fungitoxic activity in Sclerotinia sclerotiorum assessed as viability in volatile phase at 670 umol/l measured at 20 degC after 5 days relative to control2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID692245Induction of p53 R273H mutant depletion in human SW480 cells at 10 uM by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID611170Cell cycle arrest in human A549 cells assessed as accumulation at G0/G1 phase at 10 uM after 48 hrs using propidium iodide staining by flow cytometry (Rvb = 62 +/- 1.2 %)2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Synthesis and antiproliferative activity of novel α- and β-dialkoxyphosphoryl isothiocyanates.
AID692157Induction of p53 G245C mutant depletion in human NCI-H596 cells at 15 uM by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID436140Antiproliferative activity against human LTEP-A2 cells by trypan blue exclusion assay2008Journal of natural products, Nov, Volume: 71, Issue:11
Sulforaphane induces cell-cycle arrest and apoptosis in cultured human lung adenocarcinoma LTEP-A2 cells and retards growth of LTEP-A2 xenografts in vivo.
AID715957Inhibition of growth in wild type MEF cells after 6 days2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2.
AID1105156Antifungal activity against Sclerotinia sclerotiorum assessed as inhibition of germination in volatile phase at 335 umol/l measured at 20 degC after 5 days2011Pest management science, Jul, Volume: 67, Issue:7
In vitro and in vivo antifungal activity of synthetic pure isothiocyanates against Sclerotinia sclerotiorum.
AID1209284Mixed inhibition of CYP2A6 (unknown origin)2012Drug metabolism and disposition: the biological fate of chemicals, Sep, Volume: 40, Issue:9
Evaluation of inhibition selectivity for human cytochrome P450 2A enzymes.
AID611160Antiproliferative activity against human MCF7 cells after 72 hrs by SRB assay2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Synthesis and antiproliferative activity of novel α- and β-dialkoxyphosphoryl isothiocyanates.
AID1212108Drug metabolism assessed as human CYP2E1-mediated phenethyl isocyanate-GSH conjugate formation at 50 uM in presence of reductase and NADPH after 30 mins by LC-MS/MS method2013Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
The inactivation of human CYP2E1 by phenethyl isothiocyanate, a naturally occurring chemopreventive agent, and its oxidative bioactivation.
AID611263Reduction in glutathione levels in human A549 cells at 10 uM after 30 mins by Ellmans assay relative to control2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Synthesis and antiproliferative activity of novel α- and β-dialkoxyphosphoryl isothiocyanates.
AID1212096Inactivation of human CYP2E1 expressed in Escherichia coli MV1304 assessed as remaining P450 level at 25 uM after dialysis by CO difference spectral method2013Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
The inactivation of human CYP2E1 by phenethyl isothiocyanate, a naturally occurring chemopreventive agent, and its oxidative bioactivation.
AID716152Inhibition of mTORC1 in p53-/-TSC2-/- MEF cells assessed as reduction of p70S6K phosphorylation at threonine 389 after 3 hrs by immunoblotting analysis2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Natural product-derived antitumor compound phenethyl isothiocyanate inhibits mTORC1 activity via TSC2.
AID1816800Induction of apoptosis in human MDA-MB-468 cells expressing p53 R273H mutant assessed as increase in level of cleaved PARP1 level at 6 to 12 uM measured after 24 hrs by western blotting analysis2021Journal of medicinal chemistry, 05-27, Volume: 64, Issue:10
Adamantyl Isothiocyanates as Mutant p53 Rescuing Agents and Their Structure-Activity Relationships.
AID611255Cell cycle arrest in human A549 cells assessed as accumulation at G2/M phase at 10 uM after 48 hrs using propidium iodide staining by flow cytometry (Rvb = 13.5 +/- 0.7 %)2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Synthesis and antiproliferative activity of novel α- and β-dialkoxyphosphoryl isothiocyanates.
AID682140TP_TRANSPORTER: increase in Daunomycin intracellular accumulation (Daunomycin: 0.05 uM, Phenylhexyl isothiocyanate: 100 uM) in PANC-1 cells2002Pharmaceutical research, Oct, Volume: 19, Issue:10
Effect of organic isothiocyanates on the P-glycoprotein- and MRP1-mediated transport of daunomycin and vinblastine.
AID692260Induction of apoptosis in human NCI-H596 cells expressing p53 G245C mutant assessed as caspase-3 activation incubated for 24 hrs2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID101366Median growth inhibitory concentration of compound tested in vitro against human leukemia 60 cells2000Bioorganic & medicinal chemistry letters, Jan-03, Volume: 10, Issue:1
Antitumour activity of sphingoid base adducts of phenethyl isothiocyanate.
AID692158Effect on DR5 protein expression in human NCI-H596 cells by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID692242Induction of p53 R280K mutant depletion in human MDA-MB-231 cells at 15 uM by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID1209278Binding affinity to CYP2A6 (unknown origin) assessed as type 1 interaction as increase in absorbance 379 to 387 nm and decrease in 414 to 420 nm2012Drug metabolism and disposition: the biological fate of chemicals, Sep, Volume: 40, Issue:9
Evaluation of inhibition selectivity for human cytochrome P450 2A enzymes.
AID1209285Ratio of Ki for CYP2A6 (unknown origin) to Ki for CYP2A13 (unknown origin)2012Drug metabolism and disposition: the biological fate of chemicals, Sep, Volume: 40, Issue:9
Evaluation of inhibition selectivity for human cytochrome P450 2A enzymes.
AID624688Mechanism based inhibition of rat cytochrome P450 CYP2B1 measured by 7-EFC O-deethylation activity2005Current drug metabolism, Oct, Volume: 6, Issue:5
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
AID1212091Inhibition of human CYP2E1 expressed in Escherichia coli MV1304 assessed as half life for enzyme inactivation by measuring reduction in 7-EFC O-de-ethylation activity by spectrofluorometry based double reciprocal plot2013Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 41, Issue:4
The inactivation of human CYP2E1 by phenethyl isothiocyanate, a naturally occurring chemopreventive agent, and its oxidative bioactivation.
AID692256Induction of p53 R280K mutant depletion in human MDA-MB-231 cells at 10 uM by immunoblot analysis2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
AID1805801Various Assay from Article 10.1021/acs.jmedchem.1c00409: \\Perspectives on SARS-CoV-2 Main Protease Inhibitors.\\2021Journal of medicinal chemistry, 12-09, Volume: 64, Issue:23
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (490)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (0.41)18.7374
1990's84 (17.14)18.2507
2000's136 (27.76)29.6817
2010's225 (45.92)24.3611
2020's43 (8.78)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials7 (1.40%)5.53%
Reviews25 (4.99%)6.00%
Case Studies1 (0.20%)4.05%
Observational0 (0.00%)0.25%
Other468 (93.41%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (5)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase I Study of Phenethyl Isothiocyanate (PEITC) in Patients With Lymphoproliferative Disorders Previously Treated With Fludarabine [NCT00968461]Phase 10 participants (Actual)Interventional2013-05-31Withdrawn
Randomized Trial of PEITC as a Modifier of NNK Metabolism in Smokers [NCT00691132]Phase 2107 participants (Actual)Interventional2009-02-28Completed
A Phase I - Part B Multiple Dose Trial of Phenethyl Isothiocyanate [NCT00005883]Phase 10 participants InterventionalCompleted
Safety, Tolerability, and Pharmacokinetics of Single Rising Oral Doses of BI 1839100 in Healthy Male Subjects (Single-blind, Randomised, Placebo-controlled, Parallel Group Design) [NCT05354453]Phase 1104 participants (Actual)Interventional2022-05-23Completed
Isothiocyanates and Metabolic Health [NCT05070585]Phase 1/Phase 212 participants (Anticipated)Interventional2021-10-20Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

TrialOutcome
NCT00691132 (6) [back to overview]Urinary Levels of [Pyridine-D4]Hydroxy Acid:Total [Pyridine-D4]NNAL Ratio by GSTM1 and GSTT1 Genotype.
NCT00691132 (6) [back to overview]Combined Effects of GSTM1 and GSTT1 Genotype on Phenethyl Isothiocyanate (PEITC)-NNK Association and on the Metabolism and Excretion of PEITC
NCT00691132 (6) [back to overview]Effects of GSTM1 Genotype on Phenethyl Isothiocyanate (PEITC)-NNK Association and on the Metabolism and Excretion of PEITC
NCT00691132 (6) [back to overview]Effects of GSTT1 Genotype on Phenethyl Isothiocyanate (PEITC)-NNK Association and on the Metabolism and Excretion of PEITC
NCT00691132 (6) [back to overview]Urinary Levels of Biomarkers of NNK Metabolism
NCT00691132 (6) [back to overview]Urinary Levels of Biomarkers of NNK Metabolism

Urinary Levels of [Pyridine-D4]Hydroxy Acid:Total [Pyridine-D4]NNAL Ratio by GSTM1 and GSTT1 Genotype.

% Difference in ratio of urinary [pyridine-D4]hydroxy acid : total [pyridine-D4]NNAL while on PEITC compared to while on Placebo ((PEITC - Placebo) / PEITC) x 100% (NCT00691132)
Timeframe: After 5 days of treatment

Interventionpercentage of change in ratio (Geometric Mean)
GSTM1 and GSTT1 Both Genes Null-15.6
GSTM1 and GSTT1 Only One Gene Present-3.1
GSTM1 and GSTT1 Both Genes Present-9.4

[back to top]

Combined Effects of GSTM1 and GSTT1 Genotype on Phenethyl Isothiocyanate (PEITC)-NNK Association and on the Metabolism and Excretion of PEITC

(NCT00691132)
Timeframe: After 5 days of treatment

,,
Interventionnmol/mg creatinine (Geometric Mean)
PEITC-NACTotal ITC
GSTM1 and GSTT1 Both Genes Null85.459.6
GSTM1 and GSTT1 Both Genes Present56.941.5
GSTM1 and GSTT1 Only One Gene Present60.547.1

[back to top]

Effects of GSTM1 Genotype on Phenethyl Isothiocyanate (PEITC)-NNK Association and on the Metabolism and Excretion of PEITC

Measured by high-performance liquid chromatography (HPLC). The aim is to determine the possible differential effects of GSTM1 genotype on PEITC excretion, using the method of Chung et al. The method will result in quantitative recovery of the PEITC-NAC. (NCT00691132)
Timeframe: After 5 days of PEITC treatment

,
Interventionnmol/mg creatinine (Geometric Mean)
PEITC-NACTotal ITC
GSTM1 Null71.753.7
GSTM1 Present54.840.5

[back to top]

Effects of GSTT1 Genotype on Phenethyl Isothiocyanate (PEITC)-NNK Association and on the Metabolism and Excretion of PEITC

Measured by high-performance liquid chromatography (HPLC). The aim is to determine the possible differential effects of GSTT1 genotype on PEITC excretion, using the method of Chung et al. The method will result in quantitative recovery of the PEITC-NAC. (NCT00691132)
Timeframe: After 5 days of treatment

,
Interventionnmol/mg creatinine (Geometric Mean)
PEITC-NACTotal ITC
GSTT1 Null67.149.2
GSTT1 Present60.445.1

[back to top]

Urinary Levels of Biomarkers of NNK Metabolism

The ratio of urinary [pyridine-D4]hydroxy acid : total [pyridine-D4]NNAL will be measured. This ratio is not expected to be influenced by the number of cigarettes smoked per day, or smoking topography. (NCT00691132)
Timeframe: After 5 days of treatment

,
Interventionpmol/mg creatinine (Geometric Mean)
Total [pyridine-D4]NNAL[pyridine-D4]Hydroxy acid[pyridine-D4]Hydroxy acid :[pyridine-D4]total NNAL
PEITC0.3660.1400.420
Placebo0.3660.1500.455

[back to top]

Urinary Levels of Biomarkers of NNK Metabolism

Urinary levels of Total ITC and PEITC-NAC by treatment sequence groups and treatment period. (NCT00691132)
Timeframe: 2 periods, 5 days each on PEITC or Placebo, with washout week between

,
Interventionpmol/mg creatinine (Geometric Mean)
Period 1 - Total ITCPeriod 2 - Total ITCPeriod 1 - PEITC-NACPeriod 2 - PEITC-NAC
PEITC-Placebo42.80.2856.70.36
Placebo - PEITC0.3649.70.2768.1

[back to top]